FDA.report

Lithium Carbonate

Product NDC
62756-430
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lithium Carbonate
Dosage form
TABLET
Route
ORAL
Labeler
Sun Pharmaceutical Industries, Inc.
Application
ANDA091027
Marketing category
ANDA
Substance
LITHIUM CARBONATE
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
62756-430-08100 TABLET in 1 BOTTLE (62756-430-08) 2010-07-08NoHistorical
62756-430-181000 TABLET in 1 BOTTLE (62756-430-18) 2010-07-08NoHistorical
62756-430-8330 TABLET in 1 BOTTLE (62756-430-83) 2010-07-08NoHistorical
62756-430-88100 TABLET in 1 BOTTLE (62756-430-88) 2010-07-08NoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
These highlights do not include all the information needed to use LITHIUM CARBONATE TABLETS safely and effectively. See full prescribing information for LITHIUM CARBONATE TABLETS. LITHIUM CARBONATE tablets, for oral use Initial U.S. Approval: 1970Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited2023-10-02Human Prescription Drug Label9